• 1
    Cancer incidence of Sweden 1991. Fritzes, Stockholm: Centre of Epidemiology, National Board of Health and Welfare, 1994.
  • 2
    Woolf CM. An investigation of familial aspects of carcinoma of the prostate. Cancer 1960; 13: 73944.
  • 3
    Krain LS. Some epidemiologic variables in prostatic carcinoma in California. Prev Med 1974; 3: 1549.
  • 4
    Cannon L, Bishop DT, Skolnick M, Hunt S, Lyon JL, Smart CR. Genetic epidemiology of prostate cancer in the Utah Mormon genealogy. Cancer Surv 1982; 1: 4769.
  • 5
    Meikle AW, Smith JA, West DW. Familial factors affecting prostatic cancer risk and plasma sex-steroid levels. Prostate 1985; 6: 1218.
  • 6
    Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate 1990; 17: 33747.
  • 7
    Spitz MR, Currier RD, Fueger JJ, Babaian RJ, Newell GR. Familial patterns of prostate cancer: a case-control analysis. J Urol 1991; 146: 13057.
  • 8
    Ghadirian P, Cadotte M, Lacroix A, Perret C. Family aggregation of cancer of the prostate in Quebec: the tip of the iceberg. Prostate 1991; 19: 4352.
  • 9
    Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 1992; 89: 336771.
  • 10
    Grönberg H, Damber L, Damber J-E. Studies of genetic factors in prostate cancer in a twin population. J Urol 1994; 152: 14849.
  • 11
    Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994; 86: 16008.
  • 12
    Easton DF, Bishop DF, Crockford GP. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 1993; 52: 678701.
  • 13
    Lindblom A, Tannergård P, Werelius B, Nordenskjöld M. Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nature Genet 1993; 5: 27982.
  • 14
    Gilliland F, Becker TM, Smith A, Key CR, Samet JM. Trends in prostate cancer incidence and mortality in New Mexico are consistent with an increase in effective screening. Cancer Epidemiol Biomarkers Prev 1994; 3: 10511.
  • 15
    Grönberg H, Bergh A, Damber JE, Jonsson H, Lenner P, Ångström T. Prostate cancer in northern Sweden. Incidence, survival and mortality in relation to tumour grade. Acta Oncol 1994; 33: 35963.
  • 16
    Cannon-Albright LA, Thomas A, Goldgar DE, Gholami K, Rowe K, Jacobsen M et al. Familiality of cancer in Utah. Cancer Res 1994; 54: 237885.
  • 17
    Coleman MP, Hermon C, Douglas A. Person-Years (PYRS). A Fortran program for cohort study analysis. IARC International Report No. 89/006. Lyon: IARC, 1989.
  • 18
    Breslow NE, Day NE. Statistical methods in cancer research, vol 1. The analysis of case-control studies. Lyon: IARC Sci Publ 1980.
  • 19
    Mattsson B. Cancer registration in Sweden. Studies on completeness and validity of incidence and mortality registers (dissertation). University of Stockholm, 1984.
  • 20
    McWhorter WP, Hernandez AD, Meikle AW, Terreros DA, Smith JA Jr., Skolnick MH et al. A screening study of prostate cancer in high risk families. J Urol 1992; 148: 8268.